Exelixis Inc
F:EX9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exelixis Inc
F:EX9
|
US |
|
A
|
Atlas Copco AB
XMUN:ACO5
|
SE |
|
MillerKnoll Inc
F:MHR
|
US |
|
Tenaris SA
F:TW10
|
LU |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
|
V
|
Vestas Wind Systems A/S
F:VWSB
|
DK |
|
O
|
ONE Gas Inc
F:OG9
|
US |
|
H
|
Hydreight Technologies Inc
OTC:HYDTF
|
CA |
|
Natwest Group PLC
F:RYS
|
UK |
|
S
|
Schumag AG
DUS:SCM
|
DE |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
Penguin Solutions Inc
F:88E
|
US |
|
Bolsa Mexicana de Valores SAB de CV
F:BC51
|
MX |
|
C
|
Columbia Sportswear Co
F:CUW
|
US |
|
Graines Voltz SA
PAR:GRVO
|
FR |
|
Chemometec A/S
F:CHY
|
DK |
|
Braze Inc
F:K43
|
US |
|
P
|
PYC Therapeutics Ltd
F:PH7
|
AU |
|
Galapagos NV
F:GXE
|
BE |
|
S
|
Sensata Technologies Holding PLC
F:S94
|
US |
Bankruptcy Probability
Exelixis Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Exelixis Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Exelixis Inc
NASDAQ:EXEL
|
12.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
175.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Exelixis Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Exelixis Inc has no debt.
You can find a full breakdown on its Balance Sheet.
